Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cryosurgery | 31 | 2023 | 473 | 2.610 |
Why?
|
Magnetic Resonance Imaging, Interventional | 12 | 2018 | 189 | 1.470 |
Why?
|
Surgery, Computer-Assisted | 13 | 2020 | 1007 | 0.880 |
Why?
|
Catheter Ablation | 23 | 2023 | 2755 | 0.840 |
Why?
|
Liver Neoplasms | 24 | 2022 | 4317 | 0.770 |
Why?
|
Radiography, Interventional | 15 | 2017 | 1112 | 0.700 |
Why?
|
Prostate | 13 | 2023 | 1793 | 0.700 |
Why?
|
Prostatic Neoplasms | 23 | 2024 | 11341 | 0.660 |
Why?
|
Biopsy, Needle | 14 | 2018 | 1633 | 0.650 |
Why?
|
Kidney Neoplasms | 17 | 2023 | 4312 | 0.620 |
Why?
|
Magnetic Resonance Imaging | 45 | 2024 | 36247 | 0.610 |
Why?
|
Cryotherapy | 7 | 2020 | 162 | 0.530 |
Why?
|
Robotics | 6 | 2021 | 880 | 0.480 |
Why?
|
Needles | 7 | 2023 | 451 | 0.470 |
Why?
|
Tomography, X-Ray Computed | 38 | 2023 | 20484 | 0.440 |
Why?
|
Ablation Techniques | 4 | 2019 | 249 | 0.380 |
Why?
|
Fiducial Markers | 3 | 2020 | 132 | 0.370 |
Why?
|
Adrenal Gland Neoplasms | 4 | 2019 | 734 | 0.340 |
Why?
|
Radiology, Interventional | 8 | 2007 | 475 | 0.320 |
Why?
|
Subtraction Technique | 5 | 2016 | 510 | 0.280 |
Why?
|
Pseudomyxoma Peritonei | 1 | 2005 | 21 | 0.260 |
Why?
|
Pattern Recognition, Automated | 5 | 2016 | 988 | 0.250 |
Why?
|
Therapy, Computer-Assisted | 1 | 2007 | 267 | 0.250 |
Why?
|
Carcinoma, Renal Cell | 6 | 2020 | 3217 | 0.240 |
Why?
|
Perineum | 6 | 2019 | 209 | 0.230 |
Why?
|
Aged, 80 and over | 42 | 2023 | 58947 | 0.210 |
Why?
|
Soft Tissue Neoplasms | 2 | 2008 | 1151 | 0.200 |
Why?
|
Fluorodeoxyglucose F18 | 4 | 2021 | 2007 | 0.190 |
Why?
|
Biopsy | 10 | 2024 | 6775 | 0.190 |
Why?
|
Watchful Waiting | 2 | 2024 | 510 | 0.190 |
Why?
|
Aged | 62 | 2023 | 168995 | 0.180 |
Why?
|
Neoplasm Seeding | 2 | 2013 | 85 | 0.180 |
Why?
|
Digestive System Neoplasms | 2 | 2011 | 81 | 0.180 |
Why?
|
Motion | 3 | 2020 | 779 | 0.180 |
Why?
|
Drainage | 6 | 2004 | 1161 | 0.180 |
Why?
|
Abdominal Neoplasms | 3 | 2008 | 286 | 0.180 |
Why?
|
Male | 85 | 2024 | 359413 | 0.170 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2019 | 3335 | 0.170 |
Why?
|
Image Enhancement | 5 | 2016 | 2877 | 0.170 |
Why?
|
Monitoring, Intraoperative | 2 | 2020 | 941 | 0.170 |
Why?
|
Portal Vein | 2 | 2016 | 429 | 0.160 |
Why?
|
Retrospective Studies | 33 | 2023 | 80301 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2018 | 8945 | 0.160 |
Why?
|
Peritoneal Neoplasms | 1 | 2005 | 706 | 0.160 |
Why?
|
Middle Aged | 60 | 2023 | 220175 | 0.150 |
Why?
|
Humans | 108 | 2024 | 760261 | 0.150 |
Why?
|
Cholangiocarcinoma | 1 | 2023 | 547 | 0.140 |
Why?
|
Bile Duct Neoplasms | 1 | 2023 | 600 | 0.140 |
Why?
|
Microwaves | 2 | 2017 | 184 | 0.140 |
Why?
|
Brachytherapy | 6 | 2014 | 1240 | 0.140 |
Why?
|
Treatment Outcome | 27 | 2023 | 64947 | 0.140 |
Why?
|
Intestines | 1 | 2006 | 1907 | 0.140 |
Why?
|
Laser Therapy | 2 | 2023 | 1089 | 0.140 |
Why?
|
Software | 5 | 2019 | 4420 | 0.130 |
Why?
|
Hepatic Veins | 1 | 2016 | 111 | 0.130 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 2015 | 29 | 0.130 |
Why?
|
Bone Neoplasms | 1 | 2007 | 2532 | 0.120 |
Why?
|
Catecholamines | 1 | 2015 | 385 | 0.120 |
Why?
|
Sensitivity and Specificity | 14 | 2016 | 14656 | 0.120 |
Why?
|
Adrenalectomy | 1 | 2015 | 348 | 0.110 |
Why?
|
Models, Anatomic | 1 | 2017 | 682 | 0.110 |
Why?
|
Positron-Emission Tomography | 5 | 2021 | 6457 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2016 | 9274 | 0.110 |
Why?
|
Liver Diseases | 1 | 2002 | 1301 | 0.110 |
Why?
|
Ultrasonography, Interventional | 4 | 2024 | 1503 | 0.110 |
Why?
|
Gallbladder | 1 | 2014 | 305 | 0.100 |
Why?
|
Female | 55 | 2023 | 391011 | 0.100 |
Why?
|
Adrenal Glands | 1 | 2015 | 556 | 0.100 |
Why?
|
Adult | 41 | 2023 | 219847 | 0.100 |
Why?
|
Pelvic Neoplasms | 2 | 2005 | 248 | 0.100 |
Why?
|
Radiation Dosage | 5 | 2015 | 1957 | 0.100 |
Why?
|
Ethanol | 3 | 2008 | 1323 | 0.100 |
Why?
|
Algorithms | 9 | 2023 | 13967 | 0.090 |
Why?
|
Stomach Diseases | 1 | 1992 | 133 | 0.090 |
Why?
|
Radiometry | 2 | 2011 | 813 | 0.090 |
Why?
|
Body Burden | 1 | 2011 | 158 | 0.090 |
Why?
|
Reproducibility of Results | 12 | 2018 | 20048 | 0.090 |
Why?
|
Urography | 2 | 2009 | 312 | 0.090 |
Why?
|
Ultrasonography | 6 | 2015 | 5960 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2016 | 716 | 0.090 |
Why?
|
Fluoroscopy | 4 | 2005 | 943 | 0.090 |
Why?
|
Feasibility Studies | 7 | 2011 | 5201 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 4 | 2013 | 4044 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2931 | 0.080 |
Why?
|
Preoperative Care | 2 | 2010 | 2255 | 0.080 |
Why?
|
Kidney | 3 | 2020 | 7072 | 0.080 |
Why?
|
Artifacts | 1 | 2016 | 1893 | 0.080 |
Why?
|
Male Urogenital Diseases | 1 | 2008 | 48 | 0.070 |
Why?
|
Intestinal Diseases | 1 | 1992 | 507 | 0.070 |
Why?
|
Eosinophilia | 1 | 1992 | 560 | 0.070 |
Why?
|
Uncertainty | 1 | 2012 | 754 | 0.070 |
Why?
|
Female Urogenital Diseases | 1 | 2008 | 57 | 0.070 |
Why?
|
Myoglobin | 2 | 2011 | 159 | 0.070 |
Why?
|
Hepatectomy | 1 | 2010 | 560 | 0.070 |
Why?
|
Ice | 2 | 2023 | 102 | 0.070 |
Why?
|
Nephritis | 1 | 2007 | 149 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1293 | 0.070 |
Why?
|
Postoperative Complications | 3 | 2016 | 15680 | 0.070 |
Why?
|
Statistics, Nonparametric | 3 | 2015 | 2852 | 0.070 |
Why?
|
Kidney Tubules, Collecting | 1 | 2006 | 163 | 0.070 |
Why?
|
Furosemide | 1 | 2006 | 170 | 0.060 |
Why?
|
Kidney Diseases | 2 | 2007 | 2093 | 0.060 |
Why?
|
Pilot Projects | 5 | 2019 | 8553 | 0.060 |
Why?
|
Lung Neoplasms | 5 | 2014 | 13249 | 0.060 |
Why?
|
Phantoms, Imaging | 5 | 2018 | 2510 | 0.060 |
Why?
|
Gases | 1 | 2005 | 203 | 0.060 |
Why?
|
Intraoperative Period | 2 | 2018 | 516 | 0.060 |
Why?
|
Anesthesia, General | 2 | 2016 | 1165 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2776 | 0.060 |
Why?
|
Radiopharmaceuticals | 2 | 2011 | 2633 | 0.060 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2007 | 615 | 0.060 |
Why?
|
Hematologic Diseases | 1 | 2008 | 497 | 0.060 |
Why?
|
Sodium Chloride | 1 | 2006 | 596 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2014 | 2297 | 0.060 |
Why?
|
Brachial Plexus | 1 | 2005 | 166 | 0.060 |
Why?
|
Tumor Burden | 3 | 2015 | 1897 | 0.060 |
Why?
|
Urology | 1 | 2009 | 424 | 0.060 |
Why?
|
Contrast Media | 3 | 2017 | 5301 | 0.050 |
Why?
|
Gadolinium DTPA | 2 | 2017 | 826 | 0.050 |
Why?
|
Bile | 1 | 2003 | 296 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 2880 | 0.050 |
Why?
|
Liposarcoma | 1 | 2004 | 283 | 0.050 |
Why?
|
Nephrectomy | 1 | 2007 | 1017 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 296 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5073 | 0.050 |
Why?
|
Urethra | 1 | 2003 | 406 | 0.050 |
Why?
|
Posture | 1 | 2005 | 954 | 0.050 |
Why?
|
Neoplasms | 4 | 2016 | 22066 | 0.050 |
Why?
|
Factor Analysis, Statistical | 1 | 2003 | 998 | 0.040 |
Why?
|
Telomerase | 1 | 2005 | 747 | 0.040 |
Why?
|
Pneumothorax | 1 | 2003 | 377 | 0.040 |
Why?
|
Pelvis | 1 | 2023 | 743 | 0.040 |
Why?
|
Rectum | 1 | 2003 | 896 | 0.040 |
Why?
|
Thermal Conductivity | 1 | 2017 | 16 | 0.040 |
Why?
|
Adenocarcinoma | 3 | 2006 | 6310 | 0.040 |
Why?
|
Mathematical Concepts | 1 | 2017 | 73 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 2002 | 785 | 0.040 |
Why?
|
Pancreatitis | 1 | 2004 | 1100 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2003 | 1166 | 0.040 |
Why?
|
Pancreatic Neoplasms | 2 | 2006 | 5333 | 0.040 |
Why?
|
Disease Progression | 3 | 2019 | 13505 | 0.040 |
Why?
|
Piperazines | 1 | 2007 | 2520 | 0.030 |
Why?
|
Liver | 2 | 2003 | 7512 | 0.030 |
Why?
|
Predictive Value of Tests | 5 | 2015 | 15273 | 0.030 |
Why?
|
Societies, Medical | 1 | 2009 | 3903 | 0.030 |
Why?
|
Prospective Studies | 7 | 2024 | 54263 | 0.030 |
Why?
|
Radio Waves | 1 | 2017 | 250 | 0.030 |
Why?
|
Perfusion | 1 | 2021 | 1376 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2003 | 1130 | 0.030 |
Why?
|
Pain | 2 | 2008 | 5066 | 0.030 |
Why?
|
Radiation Injuries | 1 | 2003 | 1183 | 0.030 |
Why?
|
Normal Distribution | 1 | 2016 | 273 | 0.030 |
Why?
|
Ureteroscopy | 1 | 1997 | 148 | 0.030 |
Why?
|
Automation | 1 | 2018 | 581 | 0.030 |
Why?
|
Equipment Design | 2 | 2014 | 3520 | 0.030 |
Why?
|
Pyrimidines | 1 | 2007 | 3011 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2005 | 2753 | 0.030 |
Why?
|
Swine | 2 | 2021 | 5902 | 0.030 |
Why?
|
Radiology | 1 | 2009 | 2103 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3870 | 0.030 |
Why?
|
Cattle | 1 | 2020 | 3847 | 0.030 |
Why?
|
Ureter | 1 | 1997 | 375 | 0.030 |
Why?
|
Boston | 3 | 2011 | 9282 | 0.030 |
Why?
|
Ultrasonic Therapy | 2 | 2007 | 215 | 0.030 |
Why?
|
Computer Simulation | 2 | 2018 | 6210 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2221 | 0.030 |
Why?
|
Abdomen | 1 | 1999 | 1124 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2528 | 0.030 |
Why?
|
Palliative Care | 1 | 2008 | 3607 | 0.030 |
Why?
|
Linear Models | 1 | 2003 | 5876 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2016 | 698 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5230 | 0.030 |
Why?
|
Ileal Diseases | 1 | 1992 | 69 | 0.030 |
Why?
|
Radiography | 3 | 2013 | 6965 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 848 | 0.020 |
Why?
|
Echo-Planar Imaging | 1 | 2016 | 657 | 0.020 |
Why?
|
Carcinoma | 1 | 2003 | 2334 | 0.020 |
Why?
|
Lung | 2 | 2014 | 9989 | 0.020 |
Why?
|
Survival Analysis | 2 | 2019 | 10185 | 0.020 |
Why?
|
Risk Assessment | 2 | 2015 | 24086 | 0.020 |
Why?
|
Hyperplasia | 1 | 2015 | 1158 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3568 | 0.020 |
Why?
|
Preoperative Period | 1 | 2013 | 555 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2022 | 6545 | 0.020 |
Why?
|
Colonic Diseases | 1 | 1992 | 200 | 0.020 |
Why?
|
Physicians | 1 | 2009 | 4590 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 2008 | 8551 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2000 | 1809 | 0.020 |
Why?
|
Relative Biological Effectiveness | 1 | 2011 | 312 | 0.020 |
Why?
|
Calibration | 1 | 2012 | 816 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2011 | 415 | 0.020 |
Why?
|
Hematocrit | 1 | 2011 | 630 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2015 | 1439 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2011 | 524 | 0.020 |
Why?
|
Bilirubin | 1 | 2011 | 438 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1490 | 0.020 |
Why?
|
Movement | 1 | 2016 | 1474 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1577 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2557 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 1992 | 435 | 0.020 |
Why?
|
Prostatectomy | 1 | 2017 | 1956 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2011 | 607 | 0.020 |
Why?
|
Platelet Count | 1 | 2011 | 777 | 0.020 |
Why?
|
Data Collection | 2 | 2009 | 3317 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2011 | 865 | 0.020 |
Why?
|
Safety | 1 | 2012 | 1149 | 0.020 |
Why?
|
Organ Size | 1 | 2012 | 2249 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2012 | 1008 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2003 | 4024 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2007 | 13629 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2011 | 1600 | 0.020 |
Why?
|
Pancreas | 2 | 2004 | 1677 | 0.020 |
Why?
|
Risk Factors | 4 | 2016 | 74269 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8449 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4127 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2696 | 0.020 |
Why?
|
Time Factors | 3 | 2014 | 40133 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2007 | 367 | 0.020 |
Why?
|
Creatinine | 1 | 2011 | 1906 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12532 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6771 | 0.020 |
Why?
|
Chromans | 1 | 2004 | 117 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2012 | 2325 | 0.010 |
Why?
|
Pancreatic Pseudocyst | 1 | 2004 | 110 | 0.010 |
Why?
|
Incidence | 2 | 2016 | 21378 | 0.010 |
Why?
|
History, 18th Century | 1 | 2004 | 207 | 0.010 |
Why?
|
Neural Conduction | 1 | 2005 | 441 | 0.010 |
Why?
|
Paralysis | 1 | 2005 | 251 | 0.010 |
Why?
|
Clone Cells | 1 | 2007 | 1663 | 0.010 |
Why?
|
Injections, Intralesional | 1 | 2004 | 278 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2007 | 729 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2009 | 21065 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9712 | 0.010 |
Why?
|
Follow-Up Studies | 4 | 2006 | 39254 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12806 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2007 | 1493 | 0.010 |
Why?
|
Reoperation | 1 | 2013 | 4292 | 0.010 |
Why?
|
United States | 3 | 2023 | 72363 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12156 | 0.010 |
Why?
|
Bile Ducts | 1 | 2003 | 282 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2007 | 12968 | 0.010 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2004 | 629 | 0.010 |
Why?
|
Thorax | 1 | 2005 | 553 | 0.010 |
Why?
|
Benzamides | 1 | 2007 | 1369 | 0.010 |
Why?
|
Radiology Department, Hospital | 1 | 2005 | 405 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2004 | 505 | 0.010 |
Why?
|
Thiazolidinediones | 1 | 2004 | 465 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2006 | 709 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1992 | 3023 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13311 | 0.010 |
Why?
|
Abscess | 1 | 2004 | 605 | 0.010 |
Why?
|
Animals | 3 | 2021 | 167940 | 0.010 |
Why?
|
Thermoluminescent Dosimetry | 1 | 2000 | 27 | 0.010 |
Why?
|
Electric Impedance | 1 | 2005 | 751 | 0.010 |
Why?
|
Necrosis | 1 | 2004 | 1612 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9468 | 0.010 |
Why?
|
Peritoneum | 1 | 2000 | 225 | 0.010 |
Why?
|
Catheterization | 1 | 2004 | 1432 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1884 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29636 | 0.010 |
Why?
|
Models, Animal | 1 | 2005 | 2117 | 0.010 |
Why?
|
Pain Measurement | 1 | 2008 | 3514 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 1999 | 488 | 0.010 |
Why?
|
Muscular Diseases | 1 | 2002 | 551 | 0.010 |
Why?
|
Length of Stay | 1 | 2011 | 6472 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1999 | 429 | 0.010 |
Why?
|
Young Adult | 2 | 2016 | 58673 | 0.010 |
Why?
|
Prostatic Hyperplasia | 1 | 2000 | 531 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2005 | 1411 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 2003 | 1469 | 0.010 |
Why?
|
Adolescent | 2 | 2016 | 87747 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7268 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2003 | 1423 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 22041 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2003 | 2811 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2006 | 11141 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2005 | 12412 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7468 | 0.010 |
Why?
|
Patient Selection | 1 | 2000 | 4276 | 0.000 |
Why?
|